Endocrine Pathology

, Volume 28, Issue 3, pp 247–252 | Cite as

Differences in Clinical Features Between Subcategories of “Atypia/Follicular Lesion of Undetermined Significance”

  • Seong Dong Kim
  • Seung Hoon Han
  • Woo-Jin Jeong
  • Hyojin Kim
  • Soon Hyun Ahn
Article

Abstract

Within the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), category III (atypia or follicular lesion of undetermined significance (AUS/FLUS)) comprises specimens with heterogeneous features and the need for subcategorization has been reported. We compared the clinical features of two subgroups from within the category of AUS/FLUS to determine precise guidelines for clinicians who explain the results of fine-needle aspiration (FNA) to patients. Retrospective review was performed including data from all patients who underwent FNA with results reported as AUS/FLUS at a single tertiary hospital from January 2010 to August 2014. The results of repeated FNA, core needle biopsy, and diagnostic surgery were analyzed. Of the 903 patients with results categorized as AUS/FLUS, 500 were subcategorized as cellular atypia and 160 as architectural atypia. On repeated biopsy, diagnostic results were obtained for 78.9% patients of the cellular atypia group, compared to only 54.3% of the architectural atypia group (p < 0.0001). The rate of neoplasm or malignancy was also significantly higher in the cellular atypia group compared to the architectural atypia group (51.8 vs. 25.2%, p < 0.0001, 48.2 vs. 14.2%, p < 0.0001). Therefore, clinicians can inform patients with architectural atypia that the risk of malignancy is low. However, the high rate of non-diagnostic results on repeated biopsy makes clinical decisions difficult. The data of the present study revealed the necessity of subcategorization of category III of TBSRTC in the future.

Keywords

Thyroid Fine-needle aspiration Atypia or follicular lesion of undetermined significance Subclassification 

References

  1. 1.
    Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid : Official Journal of the American Thyroid Association 19 (11):1159–1165. doi: 10.1089/thy.2009.0274 CrossRefGoogle Scholar
  2. 2.
    Jo VY, Stelow EB, Dustin SM, Hanley KZ (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. American Journal of Clinical Pathology 134 (3):450–456. doi: 10.1309/AJCP5N4MTHPAFXFB CrossRefPubMedGoogle Scholar
  3. 3.
    Mufti ST, Molah R (2012) The Bethesda System for Reporting Thyroid Cytopathology: a five-year retrospective review of one center experience. International Journal of Health Sciences 6 (2):159–173CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Salillas AL, Sun FC, Almocera EG (2015) Review of the Bethesda System for Reporting Thyroid Cytopathology: a local study in Bohol Island, Philippines. Acta cytologica 59 (1):77–82. doi: 10.1159/000371752 CrossRefPubMedGoogle Scholar
  5. 5.
    Choi YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Kim JK, Song DE, Shong YK, Hong SJ (2014) Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy. Thyroid : Official Journal of the American Thyroid Association 24 (3):494–501. doi: 10.1089/thy.2012.0635 CrossRefGoogle Scholar
  6. 6.
    Renshaw AA (2011) Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathology 119 (5):322–327. doi: 10.1002/cncy.20154 CrossRefPubMedGoogle Scholar
  7. 7.
    Wu HH, Inman A, Cramer HM (2014) Subclassification of “atypia of undetermined significance” in thyroid fine-needle aspirates. Diagnostic Cytopathology 42 (1):23–29. doi: 10.1002/dc.23052 CrossRefPubMedGoogle Scholar
  8. 8.
    Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD (2017) American Thyroid Association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid : Official Journal of the American Thyroid Association 27 (4):481–483. doi: 10.1089/thy.2016.0628 CrossRefGoogle Scholar
  9. 9.
    Park KT, Ahn SH, Mo JH, Park YJ, Park DJ, Choi SI, Park SY (2011) Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head Neck 33 (2):160–165. doi: 10.1002/hed.21414 CrossRefPubMedGoogle Scholar
  10. 10.
    Olson MT, Clark DP, Erozan YS, Ali SZ (2011) Spectrum of risk of malignancy in subcategories of “atypia of undetermined significance”. Acta Cytologica 55 (6):518–525. doi: 10.1159/000333232 CrossRefPubMedGoogle Scholar
  11. 11.
    Horne MJ, Chhieng DC, Theoharis C, Schofield K, Kowalski D, Prasad ML, Hammers L, Udelsman R, Adeniran AJ (2012) Thyroid follicular lesion of undetermined significance: evaluation of the risk of malignancy using the two-tier sub-classification. Diagnostic Cytopathology 40 (5):410–415. doi: 10.1002/dc.21790 CrossRefPubMedGoogle Scholar
  12. 12.
    Park HJ, Moon JH, Yom CK, Kim KH, Choi JY, Choi SI, Ahn SH, Jeong WJ, Lee WW, Park SY (2014) Thyroid “atypia of undetermined significance” with nuclear atypia has high rates of malignancy and BRAF mutation. Cancer Cytopathology 122 (7):512–520. doi: 10.1002/cncy.21411 CrossRefPubMedGoogle Scholar
  13. 13.
    Hyeon J, Ahn S, Shin JH, Oh YL (2014) The prediction of malignant risk in the category “atypia of undetermined significance/follicular lesion of undetermined significance” of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results. Cancer Cytopathology 122 (5):368–376. doi: 10.1002/cncy.21396 CrossRefPubMedGoogle Scholar
  14. 14.
    Yoon JH, Kwon HJ, Kim EK, Moon HJ, Kwak JY (2016) Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS). Clinical Endocrinology 85 (2):275–282. doi: 10.1111/cen.12987 CrossRefPubMedGoogle Scholar
  15. 15.
    Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN (2014) Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120 (23):3627–3634. doi: 10.1002/cncr.29038 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Seong Dong Kim
    • 1
  • Seung Hoon Han
    • 1
  • Woo-Jin Jeong
    • 1
  • Hyojin Kim
    • 2
  • Soon Hyun Ahn
    • 1
  1. 1.Department of Otorhinolaryngology—Head & Neck SurgerySeoul National University Bundang HospitalSeongnamSouth Korea
  2. 2.Department of PathologySeoul National University Bundang Hospital, Seoul National University College of MedicineSeongnamSouth Korea

Personalised recommendations